P
Plant Response
Developing soil health solutions and advancing crop nutrition to help grow the food the world needs
About Plant Response
Plant Response began its journey in 2008 as a spin-off from the Universidad Politécnica de Madrid (UPM), founded by professors Antonio Molina and Pablo Rodríguez Palenzuela. The founders leveraged their deep scientific expertise in plant immunity and physiology to establish the company. Professor Molina, a recognized expert in plant resistance and cell wall-mediated immunity, has a background in Biochemistry and Molecular Biology and has been actively involved in technology transfer, leading to several patents and commercialized agrobiological products. His research has been pivotal in understanding how plants respond to pathogens and environmental stress.
The firm operates in the agricultural biotechnology market, developing and commercializing biological solutions for global agriculture. Its business model focuses on creating products derived from natural compounds, plants, and microorganisms that enhance crop performance. These products are sold to farmers and agricultural professionals seeking sustainable methods to improve yields and plant health. The company's revenue is generated through the sale of its diverse product portfolio. Before its acquisition, Plant Response secured significant venture capital funding from major players in the agricultural space, including Monsanto Growth Ventures, Bayer, and Novozymes, which fueled its research, development, and market expansion.
In February 2022, Plant Response was acquired by The Mosaic Company, a major global manufacturer of phosphate and potash fertilizers. This acquisition marked a strategic move for Mosaic to expand into the biologicals market and develop new soil health solutions. The integration, now known as Mosaic Biosciences, combines Plant Response's scientific capabilities with Mosaic's global reach and crop nutrition expertise. The company has a history of growth through consolidation, having previously acquired Koch Biological Solutions, Pathway BioLogic, and WISErg between 2019 and 2021.
The company's core offering is a portfolio of biological products designed to improve agricultural outcomes. These solutions are scientifically formulated to enhance nutrient use efficiency, bolster disease defense, provide biocontrol against pests, and increase tolerance to abiotic stresses like drought and heat. One key area is the development of biostimulants that help mitigate physiological damage from environmental stressors by supporting the plant's cell structure. Another product category focuses on nutrient use enhancement, utilizing microbes to break down soil-bound nutrients, making them more available to plants. The products, such as Cybelion and Neptunion, are backed by a strong intellectual property portfolio, including numerous patents.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 71.9/100
- Sub-industry
- AgriTech
- Sector
- Biotechnology, Crop Protection, Fertigation, Molecular, Spinout, Primary Production, Sustainable Development Goals, Regenerative Agriculture, Climate Tech
- Technology
- Big Data, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
- Investment activity
- 1 company, latest Apr 2021
- Capital deployed
- —
- Preferred round
- ACQUISITION
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Feb 2022 | $0 | — | The Mosaic Company | ↗ |
| DEBTDebt | Mar 2021 | $9M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Plant Response is 180 monthly website visits, down 83.6% over the last three months. Plant Response's team declined 25% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Plant Response in the Durham ecosystem
The Plant Response office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Horizon 2020 FET (Future and Emerging Technologies)
Series A7 investors entered at this stage
Monsanto
Criteria Venture Tech- MVMonsanto Growth Ventures
Middleland Capital
Novozymes
iSelect Fund
Yara International
Other known investors2 additional known investors
Technical University of Madrid
The Mosaic Company
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Plant Response on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Plant Response’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.











